GP2 and cholangiocarcinoma: The latter observation harmonizes with earlier research suggesting that anti-GP2 IgA autoantibodies enable early CCA detection in subsets of human patients30, hence indicating that our C-G2P approach captures key elements of CCA biology that have so far not been observed in animal models.